Abstract:Spray drying is one of the leading manufacturing methods for active pharmaceutical ingredients (APIs) owing to its rapid, single-step, and cost-effective nature. It also has the capacity to generate microspheres capable of controlled release of APIs including biomolecules and vaccines. However, one of the key challenges of spray-dried formulations especially with poly(lactic-co-glycolic acid) (PLGA)-based controlled-release injectables is burst release, where a significant fraction of the API is released prematurely within a short period of time following administration, leading to detrimental impact on the performance and quality of end products. This study uses a model API, bovine serum albumin (BSA) protein, to identify the sources of burst release that may affect the kinetics and performance of long-acting injectable microsphere formulations. Spray-dried microspheres with various formulations (i.e., variable BSA/PLGA ratios) were characterized in terms of their morphology, particle size, surface area, thermal properties, moisture content, as well as chemical compositions and their distributions to investigate the impact of spray drying on the burst release phenomenon. The results suggest that a relatively high initial release (85%) observed is mainly attributed to the protein distribution close to the particle surface. Morphology analysis provided evidence that the microspheres retained their spherical structure during the burst release phase. X-ray photoelectron spectroscopy, hard X-ray photoelectron spectroscopy, and argon cluster sputtering-assisted time-of-flight secondary ion mass spectrometry analysis suggest an enrichment of PLGA on particle surfaces with buried BSA protein. The statistically significant difference in particle size and surface area between three different formulations may be responsible for an initial variation in release but did not seem to alter the overall burst release profile. Considering the suggested source of burst release, the two-fluid spray-drying method, characterized by a single liquid feed delivering a preprepared emulsion, generated matrix-type microspheres with a surface layer of PLGA, as evidenced by surface analysis. The PLGA surface layer proved to be prone to degradation and pore formation, allowing for faster diffusion of BSA out of the microspheres, resulting in a burst release. Increasing the polymer concentration did not seem to halt this process.

Large Scale Production of Polylactide Microspheres for Controlled Drug Delivery

Decoration and Application of PLGA Microspheres

Modulating Drug Release from Short Poly(ethylene Glycol) Block Initiated Poly(L-lactide) Di-block Copolymers

Synthesis and Characterization of Star-Shaped Plla with Sorbitol As Core and Its Microspheres Application in Controlled Drug Release

Direct synthesis of poly(D,L-lactic acid) by melt polycondensation and its application in drug delivery

Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(ε-caprolactone) and their copolymers

Preparation, Characterization And In Vitro Release Properties Of Ibuprofen-Loaded Microspheres Based On Polylactide, Poly(Epsilon-Caprolactone) And Their Copolymers

Drug-nanoencapsulated PLGA Microspheres Prepared by Emulsion Electrospray with Controlled Release Behavior

Preparation of sPLLA/LP microspheres and its in vitro release properties

New Insights on the Burst Release Kinetics of Spray-Dried PLGA Microspheres

Fabrication and Surface Characterization of Electrosprayed Poly(l‐lactide) Microspheres

Impact of PLGA molecular behavior in the feed solution on the drug release kinetics of spray dried microparticles

Recent Advances in the Preparation Progress of Protein/peptide Drug Loaded PLA/PLGA Microspheres.

Microfluidic-Based Preparation of Plga Microspheres Facilitating Peptide Sustained-Release

Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review

Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-α,β-[N-(2-hydroxyethyl)-l-aspartamide]-g-poly(l-lactide) graft copolymers

Microfluidic preparation of monodisperse PLGA-PEG/PLGA microspheres with controllable morphology for drug release.

Generation of Porous Poly-L-lactide Microspheres by Emulsion-Combined Precipitation with a Compressed CO2 Antisolvent Process.

Preparation of PLGA Microspheres Using the Non-Toxic Glycofurol as Polymer Solvent by a Modified Phase Inversion Methodology

A Detailed View of PLGA-mPEG Microsphere Formation by Double Emulsion Solvent Evaporation Method

Sustained-Release Polylactide-Co-Glycolide Microspheres Loaded with Pre-Formulated Protein Polysaccharide Nanoparticles